SBH
ZYME icon

Segall Bryant & Hamill’s Zymeworks ZYME Stock Holding History

Segall Bryant & Hamill’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
66,836
+21,110
+46% +$536K 0.02% 473
2026
Q1 		$1.14M Buy
+45,726
New +$1.08M 0.02% 496

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Segall Bryant & Hamill's ZYME Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Zymeworks (ZYME) stake by 46% in Q2 2026, buying an estimated $536K and bringing the position to 66,836 shares worth $1.75M. The position accounts for 0.02% of the portfolio, ranked #473.

Segall Bryant & Hamill first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Segall Bryant & Hamill held 66,836 shares of Zymeworks worth $1.75M as of Q2 2026.
  • Segall Bryant & Hamill bought 21,110 Zymeworks shares in Q2 2026, an estimated $536K.
  • Zymeworks made up 0.02% of Segall Bryant & Hamill's portfolio in Q2 2026, its #473 holding.
  • Segall Bryant & Hamill first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.